In Canada, switching to a one-dose, gender-neutral vaccination program for human papillomavirus (HPV) could use vaccine doses more efficiently and prevent a similar number of cervical cancer cases, ...

Initial computational analysis demonstrated that Evaxion’s AI-Immunology™ platform can identify novel vaccine targets to combat Group A Streptococcus (GAS) New vaccine program is added to Evaxion’s ...

MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much ...

A highly promising vaccine for Hanta virus is being developed by researchers from the University of Bath. The team is led ...

Evaxion A/S has announced the initiation of a new vaccine program, EVX-B4, targeting Group A Streptococcus (GAS), a pathogen responsible for a wide range of infections globally, including severe ...

COPENHAGEN, Denmark — The United States, a nation of 343 million people with a complex and overburdened health care system, is poised to adopt the childhood vaccine recommendations used in Denmark, a ...

Silencing mRNA expression in dendritic cells did not impair T‑cell priming, including for SARS‑CoV‑2 antigens, suggesting that cross‑presentation by other cell types is sufficient to initiate immunity ...

NASHVILLE Tenn. (WKRN) — It can take more than a decade to develop a new vaccine for children. After years of research and testing, some don’t pass the safety checks. One laboratory at Vanderbilt ...

RSV and flu mRNA vaccines struggle with lower durability, higher side effects, and weak uptake, leading to program cuts and ...